The United States Food and Medication Administration approved Eli Lilly and Co’s (LLY.N) COVID-19 antibody drug for persons aged 12 and up who are at risk of severe disease on…
Latest News
-
-
The World Health Organization said on Friday that the arthritis therapy tocilizumab has been prequalified for use in patients hospitalised with severe Covid-19, in an effort to expand access to…
-
Many people get re-infected with Covid-19 within 2-3 weeks of their prior infection, but hospital authorities and health experts say the majority of these cases are minor and represent no…
-
Pfizer’s COVID-19 therapy Paxlovid received conditional clearance from China’s medical goods authority on Saturday (Feb 12), making it the first oral anti-coronavirus tablet licenced in the nation to treat the…
-
The COVID-19 virus and its numerous variations continue to plague the globe. It’s been more than two years, and there’s no sign of an end in sight. In this context,…
-
Governments all over the world are eager to put Covid-19 behind them two years after the pandemic began. However, some of the most difficult work for scientists and public health…